文献速递主动脉疾病内脏/肾动脉与血管畸形

双分支腔内治疗复杂主动脉瘤的多中心早期经验

Early Experience With the Twin Branch in the Endovascular Treatment of Complex Aortic Aneurysms: A Multicenter Retrospective Study.
PubMed 文献 · J Endovasc Ther · 2026-04-06

该多中心回顾性研究纳入13例使用Artivion E-xtra Design MultiBranch支架双分支组件治疗复杂主动脉瘤的患者,平均年龄72.4岁,平均瘤径63.2mm。结论认为双分支对于特定解剖变异的复杂主动脉瘤可行,建议同时充盈桥接支架。

要点

  • 双分支技术成功率高,短期无死亡或破裂。
  • 1例无症状SMA支架闭塞,与序贯而非同时充盈桥接支架有关。
  • 建议同时充盈双分支的桥接支架以维持靶血管通畅。

核心结论

  • 双分支是治疗具有特定解剖变异的复杂主动脉瘤的可行选择。
  • 应同时充盈两个桥接支架以避免影响已充盈的支架。

研究设计与样本

  • 多中心回顾性研究,7个中心,2023年3月至2025年3月。
  • 纳入13例植入含双分支支架 graft 的患者。
  • 中位随访4.4个月(四分位距2.3-7.4)。

主要发现

  • 平均年龄72.4(±9.4)岁,平均主动脉瘤直径63.2(±13.5)mm。
  • 1例术后11周发生无症状的SMA支架 graft 闭塞,该例双分支桥接支架为序贯充盈而非同时充盈。
  • 无双分支相关内漏。

关键数值与推荐

  • 双分支使用指征:腹腔干早期分支5例,SMA与腹腔干共干3例,粗大副肾动脉3例,烟囱支架起源紧邻1例,经内膜破口插管SMA和腹腔干1例。

临床怎么用

  • 对于内脏血管起源紧邻、主动脉管腔过窄无法使用外分支的复杂主动脉瘤,可考虑双分支组件。
  • 术中应同时充盈双分支的桥接支架,避免序贯充盈导致已充盈支架受压。

局限性

  • 回顾性设计,样本量小(13例),随访时间短(中位4.4个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to report on the early results of the twin branch as part of the Artivion E-xtra Design MultiBranch stent graft in the treatment of complex aortic aneurysms. METHODS: We conducted a retrospective review of all implanted stent grafts containing a twin branch in 7 centers between March 2023 and March 2025. Outcomes of interest included baseline characteristics, technical success, twin branch-related events and short-term clinical and radiological outcomes. RESULTS: Thirteen patients were identified and included. Mean age was 72.4 (±9.4) and mean aortic aneurysm diameter was 63.2 (±13.5). The indication for the twin branch was an early division of the celiac artery (CA) in 5 cases, a common ostium of the superior mesenteric artery (SMA) and CA in 3 cases, a large accessory renal artery in 3 cases, closely-originating chimneys in one and cannulation of the SMA and CA through an intimal entry tear in the last patient. Median follow-up was 4.4 (interquartile range: 2.3-7.4) months. Technical success was achieved in all cases; no mortality nor rupture occurred. There was 1 asymptomatic occlusion of an SMA stent graft incorporated into the twin branch at 11 weeks postoperatively. In this case, the twin branch bridging stents were inflated sequentially and not simultaneously. There was no twin branch-related endoleak. CONCLUSION: The twin branch is a feasible option in the treatment of complex aortic aneurysms with certain anatomic variations. Simultaneous inflation of both stent grafts should be performed to avoid compromising a previously-inflated stent graft.Clinical ImpactThe twin branch was developed as a component of the E-xtra Design MultiBranch stent graft system (Artivion, Hechingen, Germany). In this multicenter retrospective study, we demonstrate that the twin branch is a feasible option in the treatment of complex aortic aneurysms where a regular F/BEVAR is not possible because of the visceral vessels originating in close proximity to each other and where the aortic lumen is too narrow to allow for external branches. The short-term outcomes show a good technical success rate. Simultaneous insufflation of bridging stents might be beneficial to maintain target vessel patency..

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Winckelmans T, Maleux G, Mufty H, et al. Early Experience With the Twin Branch in the Endovascular Treatment of Complex Aortic Aneurysms: A Multicenter Retrospective Study. J Endovasc Ther. 2026. PMID: 41943564. doi:10.1177/15266028261434175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。